ErythromycinAcistrate Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Erythromycin acistrate is a prodrug of erythromycin with lowered liver toxicity, improved phmacokinetics, and greatly reduced gastro-intestinal side-effects. It is indicated for respiratory tract infections, skin infections and chlamydial urethritis.

Verwenden

Antibacterial.

ErythromycinAcistrate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ErythromycinAcistrate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19853	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58

---

• ErythromycinAcistrate
• [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] acetate
• 96128-89-1
• C57H105NO16